Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

计划入组 35 人 · 首次发布于 2023 年 8 月 16 日

Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy

计划入组 30 人 · 首次发布于 2023 年 6 月 13 日

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

计划入组 9 人 · 首次发布于 2023 年 1 月 13 日

rsPSMA Vaccine

111In-PSMA-Trillium

64Cu-PSMA I&T

ANTIGEN LABORATORIES INC.

United States

NEW YORK PROSTATE INSTITUTE

United States

PROSTATE LASER CENTER, PLLC

United States

Advancements in PSMA-Targeted Radionuclide Therapy for Metastatic Prostate Cancer

Convergent Therapeutics Advances Prostate Cancer Therapy with Phase II Trial and $40M Funding

Lantheus' SPLASH Trial: пиrogress in Metastatic Castration-Resistant Prostate Cancer